14-3-3σ is required to prevent mitotic catastrophe after DNA damage

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803

Universal control mechanism regulating onset of M-phase

Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798

CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals

Fornerod, M. W. J., Ohno, M., Yoshida, M., & Mattaj, I. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80371-2 · Cited by 2,086

Mitotic and G 2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216

Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341

Is a p53-Regulated Inhibitor of G2/M Progression

Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251

CRM1 is responsible for intracellular transport mediated by the nuclear export signal

Fukuda, M., Asano, S., Nakamura, T., Adachi, M., Yoshida, M., Yanagida, M., & Nishida, E. (1997) · Nature · doi:10.1038/36894 · Cited by 1,213

p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

Waldman, T. A., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 1,188

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728

Surfing the p53 network

Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607

The DNA damage response: putting checkpoints in perspective

Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213

Chk1 is an essential kinase that is regulated by Atr and required for the G 2 /M DNA damage checkpoint

Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625

14-3-3 Proteins: Structure, Function, and Regulation

Fu, H., Subramanian, R. R., & Masters, S. C. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.617 · Cited by 1,596

Regulation of the G2/M transition by p53

Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,584

Overview of cell death signaling pathways

Jin, Z., & El‐Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,345

DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2

Hirao, A., Kong, Y., Matsuoka, S., Wakeham, A. C., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,311

PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells

Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,289

Cell death by mitotic catastrophe: a molecular definition

Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085

Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11

Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., Liao, P., Zhou, J., Zhang, Q., Dow, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0338 · Cited by 1,094

Pathways of apoptotic and non-apoptotic death in tumour cells

Okada, H., & Mak, T. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1412 · Cited by 1,066

Census and evaluation of p53 target genes

Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971

ATR disruption leads to chromosomal fragmentation and early embryonic lethality

Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951

The role of apoptosis in cancer development and treatment response

Brown, J. M., & Attardi, L. D. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1560 · Cited by 956

Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome

Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M. L., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 899

14-3-3 proteins: A historic overview

Aitken, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.005 · Cited by 842

Toward Maintaining the Genome: DNA Damage and Replication Checkpoints

Nyberg, K. A., Michelson, R. J., Putnam, C. W., & Weinert, T. A. (2002) · Annual Review of Genetics · doi:10.1146/annurev.genet.36.060402.113540 · Cited by 793

If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells

Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 720

Defying death after DNA damage

Rich, T., Allen, R. L., & Wyllie, A. H. (2000) · Nature · doi:10.1038/35037717 · Cited by 724

Death through a tragedy: mitotic catastrophe

Vakifahmetoglu, H., Olsson, M., & Zhivotovsky, B. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.47 · Cited by 700

How do 14‐3‐3 proteins work? – Gatekeeper phosphorylation and the molecular anvil hypothesis

Yaffe, M. B. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03288-4 · Cited by 663

Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin

O’Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 612

The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development

Morrison, D. K. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.10.003 · Cited by 609

Tumor Suppressive Functions of p53Preprint

Zilfou, J. T., & Lowe, S. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001883 · Cited by 611

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks

Pommier, Y. G., Sordet, O., Antony, S., Hayward, R. L., & Kohn, K. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207515 · Cited by 563

14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis

van Hemert, M. J., Steensma, H. Y., & van Heusden, G. P. H. (2001) · BioEssays · doi:10.1002/bies.1134 · Cited by 535

Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes

MacKintosh, C. (2004) · Biochemical Journal · doi:10.1042/bj20031332 · Cited by 532

Oxidative stress and cell cycle checkpoint function11Both Drs. Paules and Kaufmann received their doctoral degrees in Experimental Pathology from the University of North Carolina at Chapel Hill School of Medicine (in 1984 and 1979, respectively).

Shackelford, R. E., Kaufmann, W. K., & Paules, R. S. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00224-0 · Cited by 527

Specific inhibition of gene expression using a stably integrated, inducible small‐interfering‐RNA vector

van de Wetering, M., Oving, I. M., Muncan, V., Fong, M. T. P., Brantjes, H., van Leenen, D., Holstege, F. C. P., Brummelkamp, T. R., Agami, R., & Clevers, H. C. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor865 · Cited by 515

P53 and radiation responses

Fei, P., & El‐Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206677 · Cited by 503

14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine Phosphorylation

Tzivion, G., & Avruch, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100059200 · Cited by 490

DNA damage checkpoint control in cells exposed to ionizing radiation

Iliakis, G. E., Wang, Y., Guan, J., & Wang, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206682 · Cited by 494

Cell cycle checkpoint signaling:

Pietenpol, J. A., & Stewart, Z. A. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00460-2 · Cited by 473

Anticancer drug targets: cell cycle and checkpoint control

Shapiro, G. I., & Harper, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci9054 · Cited by 462

Unlocking the code of 14-3-3

Dougherty, M. K., & Morrison, D. K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01171 · Cited by 468

DNA methylation and breast carcinogenesis

Widschwendter, M., & Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205606 · Cited by 460

CpG methylation is maintained in human cancer cells lacking DNMT1

Rhee, I. P., Jair, K., Yen, R.-W. C., Christoph Lengauer, C., Herman, J. G., Kinzler, K. W., Vogelstein, B., Baylin, S. B., & Schuebel, K. E. (2000) · Nature · doi:10.1038/35010000 · Cited by 453

High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer

Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A.-T., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100566997 · Cited by 444

The 14-3-3 cancer connection

Hermeking, H. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1230 · Cited by 436

Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy

Bullock, A. N., Henckel, J., & Fersht, A. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203434 · Cited by 440

Ferredoxin reductase affects p53-dependent, 5-fluorouracil–induced apoptosis in colorectal cancer cells

Hwang, P. M., Bunz, F., Yu, J., Rago, C., Chan, T. A.-T., Murphy, M. P., Kelso, G. F., Smith, R. A. J., Kinzler, K. W., & Vogelstein, B. (2001) · Nature Medicine · doi:10.1038/nm1001-1111 · Cited by 430

Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts

Guo, Z., Kumagai, A., Wang, S. X., & Dunphy, W. G. (2000) · Genes & Development · doi:10.1101/gad.842500 · Cited by 417

14-3-3 proteins: regulation of subcellular localization by molecular interference

Muslin, A. J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00131-5 · Cited by 417

Structural basis for protein–protein interactions in the 14-3-3 protein family

Yang, X., Lee, W. H., Sobott, F., Papagrigoriou, E., Robinson, C. V., Grossmann, J. G., Sundström, M., Doyle, D., & Elkins, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605779103 · Cited by 417

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

Zabludoff, S., Deng, C., Grondine, M. R., Sheehy, A. M., Ashwell, S., Caleb, B. L., Green, S. A., Haye, H. R., Horn, C. L., Janetka, J. W., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0492 · Cited by 411

Cell cycle checkpoints and their inactivation in human cancer

Molinari, M. (2000) · Cell Proliferation · doi:10.1046/j.1365-2184.2000.00191.x · Cited by 398

The G2-phase DNA-damage checkpoint

O’Connell, M. J., Walworth, N. C., & Carr, A. M. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01773-6 · Cited by 385

The evolution of diverse biological responses to DNA damage: insights from yeast and p53

Wahl, G. M., & Carr, A. M. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-e277 · Cited by 376

Securin Is Required for Chromosomal Stability in Human Cells

Jallepalli, P. V., Waizenegger, I. C., Bunz, F., Langer, S., Speicher, M. R., Peters, J., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00340-3 · Cited by 366

Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth

Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y., & Inoue, S. (2002) · Nature · doi:10.1038/nature00826 · Cited by 357

Checking out the G2/M transition

Smits, V. A. J., & Medema, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00204-4 · Cited by 359

Phosphoserine/threonine-binding domains

Yaffe, M. B., & Elia, A. E. H. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00189-7 · Cited by 350

Loss of the Forkhead Transcription Factor FoxM1 Causes Centrosome Amplification and Mitotic Catastrophe

Wonsey, D. R., & Follettie, M. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4059 · Cited by 347

Cell-cycle dysregulation and anticancer therapy

Stewart, Z. A., Westfall, M. D., & Pietenpol, J. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00026-9 · Cited by 343

Non-melanoma skin cancer: what drives tumor development and progression?

Boukamp, P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi123 · Cited by 346

14-3-3 Proteins: A Number of Functions for a Numbered Protein

Bridges, D., & Moorhead, G. B. G. (2004) · Science s STKE · doi:10.1126/stke.2422004re10 · Cited by 338

JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3

Sunayama, J., Tsuruta, F., Masuyama, N., & Gotoh, Y. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409117 · Cited by 335

The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations

Westfall, M. D., Mays, D. J., Sniezek, J. C., & Pietenpol, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2264-2276.2003 · Cited by 338

The p53 tumor suppressor participates in multiple cell cycle checkpoints

Giono, L. E., & Manfredi, J. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20689 · Cited by 342

Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch

Richardson, R. J., Dixon, J., Malhotra, S., Hardman, M. J., Knowles, L., Boot-Handford, R., Shore, P., Whitmarsh, A. J., & Dixon, M. J. (2006) · Nature Genetics · doi:10.1038/ng1894 · Cited by 325

Untitled work

(2000) · PubMed · Cited by 314

Activation and activities of the p53 tumour suppressor protein

Bálint, É., & Vousden, K. H. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2128 · Cited by 315

14-3-3 proteins in cell cycle regulation

Hermeking, H., & Benzinger, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.002 · Cited by 307

Identification of S-glutathionylated cellular proteins during oxidative stress and constitutive metabolism by affinity purification and proteomic analysis

Lind, C., Gerdes, R. G., Hamnell-Pamment, Y., Schuppe‐Koistinen, I., von Löwenhielm, H. B., Holmgren, A., & Cotgreave, I. A. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00468-x · Cited by 311

Mitosis-targeted anti-cancer therapies: where they stand

Chan, K.-S., Koh, C.-G., & Li, H. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.148 · Cited by 318

14-3-3 proteins—an update

Mhawech, P. (2005) · Cell Research · doi:10.1038/sj.cr.7290291 · Cited by 308

14-3-3 proteins; bringing new definitions to scaffolding

Tzivion, G., Shen, Y. H., & Zhu, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204777 · Cited by 300

Senescence from G2 arrest, revisited

Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300

The common and distinct target genes of the p53 family transcription factors

Harms, K. L., Nozell, S. E., & Chen, X. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3304-4 · Cited by 303

The same, only different – DNA damage checkpoints and their reversal throughout the cell cycle

Shaltiël, I. A., Krenning, L., Bruinsma, W., & Medema, R. H. (2015) · Journal of Cell Science · doi:10.1242/jcs.163766 · Cited by 310

p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes

Dohn, M. R., Zhang, S., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204427 · Cited by 300

Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy

Castedo, M., Perfettini, J., Roumier, T., Valent, A., Raslová, H., Yakushijin, K., Horne, D. A., Feunteun, J., Lenoir, G., Medema, R. H., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207572 · Cited by 291

Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer

Umbricht, C. B., Evron, E., Gabrielson, E. W., Ferguson, A. T., Marks, J. R., & Sukumar, S. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204438 · Cited by 291

Positive Regulation of Wee1 by Chk1 and 14-3-3 Proteins

Lee, J., Kumagai, A., & Dunphy, W. G. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.3.551 · Cited by 287

Replication from oriP of Epstein-Barr Virus Requires Human ORC and Is Inhibited by Geminin

Dhar, S. K., Yoshida, K., Machida, Y., Khaira, P., Chaudhuri, B., Wohlschlegel, J. A., Leffak, M., Yates, J., & Dutta, A. (2001) · Cell · doi:10.1016/s0092-8674(01)00458-5 · Cited by 290

Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: A comparison of the X-ray crystal structures of all human 14-3-3 isoforms

Gardino, A. K., Smerdon, S. J., & Yaffe, M. B. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.007 · Cited by 296

Ultraviolet radiation and cutaneous malignant melanoma

Jhappan, C., Noonan, F. P., & Merlino, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206450 · Cited by 283

Apoptosis and non-apoptotic deaths in cancer development and treatment response

de Bruin, E. C., & Medema, J. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.001 · Cited by 285

Control of the G2/M Transition

Stark, G. R., & Taylor, W. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:32:3:227 · Cited by 282

BH3-only proteins Puma and Bim are rate-limiting for γ-radiation– and glucocorticoid-induced apoptosis of lymphoid cells in vivo

Erlacher, M., Michalak, E. M., Kelly, P. N., Labi, V., Niederegger, H., Coultas, L., Adams, J. M., Strasser, A., & Villunger, A. (2005) · Blood · doi:10.1182/blood-2005-04-1595 · Cited by 267

Krüppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage

Yoon, H. S., Chen, X., & Yang, V. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211027200 · Cited by 265

14-3-3 proteins as signaling integration points for cell cycle control and apoptosis

Gardino, A. K., & Yaffe, M. B. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.008 · Cited by 268

Cooperative effects of genes controlling the G2/M checkpointPreprint

Chan, T. A.-T., Hwang, P. M., Hermeking, H., Kinzler, K. W., & Vogelstein, B. (2000) · Genes & Development · doi:10.1101/gad.14.13.1584 · Cited by 261

14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma

Lee, C., Ou, W., Mariño‐Enríquez, A., Zhu, M. J., Mayeda, M., Wang, Y., Guo, X., Brunner, A. L., Amant, F. C., French, C. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115528109 · Cited by 260

Cruciform structures are a common DNA feature important for regulating biological processes

Brázda, V., Laister, R., Jagelská, E., & Arrowsmith, C. (2011) · BMC Molecular Biology · doi:10.1186/1471-2199-12-33 · Cited by 255

14-3-3 Proteins—a focus on cancer and human disease

Wilker, E., & Yaffe, M. B. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.04.015 · Cited by 251

Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma

Chung, C. H., Parker, J. S., Ely, K., Carter, J., Yi, Y., Murphy, B. A., Ang, K. K., El‐Naggar, A. K., Zanation, A. M., Cmelak, A. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1213 · Cited by 254

Genetic disruption of PPAR δ decreases the tumorigenicity of human colon cancer cells

Park, B. H., Vogelstein, B., & Kinzler, K. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051630998 · Cited by 247

Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding

Chen, M.-S., Ryan, C. E., & Piwnica-Worms, H. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7488-7497.2003 · Cited by 234

Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy

Kim, B. M., Hong, Y., Lee, S., Liu, P., Lim, J. Y., Lee, Y. C., Lee, T., Chang, K. T., & Hong, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125991 · Cited by 243

A Structural Basis for 14-3-3σ Functional Specificity*♦

Wilker, E., Grant, R. A., Artim, S. C., & Yaffe, M. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500982200 · Cited by 233

Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.

Hirose, Y., Berger, M. S., & Pieper, R. O. (2001) · PubMed · Cited by 230

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma

Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F., Suzuki, H., Kikuchi, T., Kaneto, H., Iku, S., Ozeki, I., Karino, Y., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203898 · Cited by 229

14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth

Yang, H.-Y., Wen, Y.-Y., Chen, C.-H., Lozano, G., & Lee, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7096-7107.2003 · Cited by 229

Downregulation of 14-3-3σ Prevents Clonal Evolution and Leads to Immortalization of Primary Human Keratinocytes

Dellambra, E., Golisano, O., Bondanza, S., Siviero, E., Lacal, P. M., Molinari, M., D’Atri, S., & Luca, M. D. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.5.1117 · Cited by 224

Cellular Responses to DNA Damage: One Signal, Multiple Choices

Su, T. T. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090428 · Cited by 235

Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities

Strano, S., Fontemaggi, G., Costanzo, A., Rizzo, M. G., Monti, O., Baccarini, A., Sal, G. D., Levrero, M., Sacchi, A., Oren, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201405200 · Cited by 225

14-3-3 Proteins: A Number of Functions for a Numbered Protein

Bridges, D., & Moorhead, G. B. G. (2005) · Science s STKE · doi:10.1126/stke.2962005re10 · Cited by 230

Cell cycle: Checkpoint Maintenance

(1999) · Science Signaling · doi:10.1126/scisignal.31999tw4

Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells.

Andreassen, P. R., Lacroix, F., Lohez, O. D., & Margolis, R. L. (2001) · PubMed · Cited by 113

Inactivation of 14-3-3σ Influences Telomere Behavior and Ionizing Radiation-Induced Chromosomal Instability

Dhar, S., Squire, J. A., Hande, M. P., Wellinger, R. J., & Pandita, T. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7764-7772.2000 · Cited by 67

Regulation of the p53-MDM2 pathway by 14-3-3 σ and other proteins

Lee, M., & Lozano, G. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.009 · Cited by 108

Interplay of 14-3-3 Family of Proteins with DNA Damage-Regulated Molecules in Checkpoint Control

Lee, M., Yeung, S. J., & Yang, H.-Y. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_5 · Cited by 1